Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysis

Event: ESC Cardio-Oncology 2025

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Session: Resonating rhythms: navigating arrhythmia challenges in cardio-oncology

Access
Like
Thumbnail

Risk stratification strategies in non-Hodgkin lymphoma: case presentation

Event: ESC Cardio-Oncology 2025

Topic: Cardiovascular Toxicity Stratification

Session: Guidelines in Practice: who is at risk of cardiovascular toxicity?

Access
Like
Thumbnail

Atherosclerotic cardiovascular events associated with BTK inhibitors: a systematic review and meta-analysis of harms

Event: ESC Cardio-Oncology 2025

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Session: Poster session (1)

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources